Positive impactSector
Deven Choksey prefers Sun Pharma, Cipla for fresh buying; sees upside in Indian IT
CNBC-TV18 8 hrs ago·11 Nov 2026, 9:45 am
Deven Choksey, Managing Director at DRChoksey Finserv, has maintained a positive outlook on Laurus Labs, keeping the stock on his buy list. This comes as he continues to hold the shares, indicating confidence in the company's long-term fundamentals despite market volatility. His decision reflects a belief in the company's ability to sustain its growth trajectory in the pharmaceutical sector.
For investors, Choksey's stance suggests that Laurus Labs could offer stability and potential upside. However, he has advised waiting for a market correction before entering, which might present a better entry point. This approach helps investors manage risk while capitalizing on the stock's future performance.
What to watch next is the company's ability to execute its growth plans and navigate competitive pressures in the generic drug market. Investors should also monitor broader trends in the pharmaceutical sector, as these could influence the stock's short-term movements.
Excerpt from CNBC-TV18
Published On Nov 11, 2026 | 15:15 IST Last Updated On Nov 11, 2026 | 15:15 IST Deven Choksey, Managing Director at DRChoksey Finserv, continues to hold Divi's Labs and Laurus Labs but recommends waiting for corrections before buying them. Choksey also remains positive on Indian IT companies, citing growing AI-related…Read the original at CNBC-TV18
Affected stocks
Bullish4 stocks
Laurus Labs
LAURUSLABS Bullish
₹2,454.00
DIVISLAB
DIVISLAB Bullish
—
SUNPHARMA
SUNPHARMA Bullish
—
CIPLA
CIPLA Bullish
—
Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.
Key takeaways
- Concerns Laurus Labs (LAURUSLABS).
- Category: Sector.
- AI reads the tone as positive (potentially bullish) for the stock.
- Assessed as a significant, market-relevant update.
- Also mentions DIVISLAB, SUNPHARMA, CIPLA.
Why it matters
A meaningful update for Laurus Labs worth tracking. The tone is positive — historically associated with upward pressure, though not predictive. Use the price and stock snapshot to gauge how the market is responding.
